REQUEST A DEMO
Total
USD $0.00
Search more companies

Chong Kun Dang Pharmaceutical Corp. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Chong Kun Dang Pharmaceutical Corp. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Chong Kun Dang Pharmaceutical Corp. is an enterprise located in South Korea, with the main office in Seoul. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on November 05, 2013. There are currently 2,263 (2024) people employed by Chong Kun Dang Pharmaceutical Corp.. In Q3C2025, the company reported a net sales revenue increase of 8.07%. A growth of 4.13% was recorded in its total assets. The enterprise’s net profit margin decreased by 4.76% in 2025.

Headquarters
Chongkundang Bldg 368, Chungjeongno 3-Ga, Seodaemun-Gu
Seoul; Seoul; Postal Code: 120 756

Contact Details: Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.

Website: http://www.ckdpharm.com

Basic Information
Total Employees:
Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.
Outstanding Shares:
Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.
Registered Capital:
Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.
Financial Auditors:
Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.
Incorporation Date:
November 05, 2013
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
13.4%
Subsidiaries
Pt Ckd Otto Pharmaceuticals (Indonesia)
Company Performance
Financial values in the chart are available after Chong Kun Dang Pharmaceutical Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
8.07%
Total Operating Revenue
8.17%
Operating Profit
-36.69%
EBITDA
-6.86%
Net Profit/Loss for the Period
-50.15%
Total Assets
4.13%
Total Equity
5.58%
Operating Profit Margin
-3.24%
Net Profit Margin
-4.76%
Return on Equity (ROE)
-6.09%
Debt / Equity
-1.66%
Quick Ratio
-0.64%
Cash Ratio
-0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?